The National Cancer Treatment Alliance (NCTA) today announced that Stephen “Fred” Divers, MD, Chief Medical Officer of American Oncology Network and practicing medical oncologist and hematologist at Genesis Cancer & Blood Institute in Hot Springs, Arkansas, has been re-elected to the National Cancer Treatment Alliance (NCTA) Board of Directors.
This 30-minute educational webinar is designed for health care providers and stakeholders seeking to optimize biomarker testing strategies in breast cancer within the community oncology setting. The session provides a comprehensive overview of when and how to utilize tissue and/or liquid biopsy specimens across the breast cancer care continuum.
The National Cancer Treatment Alliance (NCTA), a national network of independent community oncology practices that works with employers to ensure their employees have access to high-quality, high-value, and local cancer care, announced today the addition of three new members to its Board of Directors.
Pursuant to the charter of the National Cancer Treatment Alliance (NCTA), and in accordance with applicable state laws, we present the 2023/2024 NCTA Public Benefit Report. This report seeks to capture our promotion of the public benefit specified in the NCTA charter and the interests of those affected by our activities.
Register and Save the Date for June 17, 2025, 2:00 PM. This 30-minute educational webinar is designed for clinicians and other providers seeking to optimize biomarker testing strategies in non-small cell lung cancer (NSCLC). The session provides a comprehensive overview of when and how to utilize tissue and liquid biopsy specimens across the NSCLC care continuum.
The National Cancer Treatment Alliance (NCTA), a national network of independent community oncology practices working to increase access to high-quality and local cancer care, announced today that it has partnered with XO Health to provide employers access to NCTA’s high-performing, high-value oncology network for their employees.
The National Cancer Treatment Alliance (NCTA), a national network of independent community oncology practices that works with employers to ensure their employees have access to high-quality, high-value, and local cancer care, announced today that Kiana Mehring, MBA, of Florida Cancer Specialists and Research Institute (FCS), has joined the NCTA Board of Directors.
The National Cancer Treatment Alliance (NCTA) held a webinar on Tuesday, August 27, at 1 p.m. ET for an overview of biomarker testing, the benefits of providing it for employees, and solutions to common barriers when making these resources available.
The National Cancer Treatment Alliance (NCTA) announced today five new member practices. NCTA now has 50 practices with 248 locations across 30 states.
The National Cancer Treatment Alliance (NCTA), a nationwide network of leading, independent community oncology practices that have joined together to help employers improve cancer care, announced today the appointment of two new board members, Mark Nelson, PharmD, Chief Executive Officer at Northwest Medical Specialties and Travis Brewer, Vice President of Payer and Public Health Strategy/Relations at Texas Oncology.
760 Lynnhaven Parkway, Suite 150
Virginia Beach, VA 23452
Receive the latest news and updates for NCTA right to your inbox.